TSBX - Turnstone Biologics Corp.
0.3324
-0.008 -2.286%
Share volume: 170,375
Last Updated: 05-07-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$0.34
-0.01
-0.02%
View ratios
Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
---|---|---|---|---|
Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
Report Date | 05-13-2024 | 08-14-2024 | 11-12-2024 | |
Total revenue | 0.000 | 0.000 | 0.000 | |
Cost of revenue | 0.000 | 0.000 | 0.000 | |
Gross profit | 0.000 | 0.000 | 0.000 | |
nan% | nan% | |||
Operating expenses | 20.691 M | 22.057 M | 18.368 M | |
Selling general and admin | 4.901 M | 4.327 M | 3.944 M | |
Research and development | 15.790 M | 17.730 M | 14.424 M | |
Total expenses | 20.691 M | 22.057 M | 18.368 M | |
6.60% | -16.72% | |||
Operating income | -20.691 M | -22.057 M | -18.368 M | |
Ebit | -20.691 M | -21.302 M | -17.848 M | |
Pretax income | -19.613 M | -21.302 M | -17.848 M | |
8.61% | -16.21% | |||
Income tax | 16.000 K | 2.000 K | -816.000 K | |
Net income basic | -19.629 M | 0.000 | 0.000 | |
100.00% | ||||
Net income | -19.629 M | -21.304 M | -17.032 M | |
-8.53% | 20.05% |